Doxorubicin-induced Cardiotoxicity is Propagated by Paracrine Signaling through Small Extracellular Vesicles
Acta Biomaterialia · 2026-10 · 223 · 503-519
DOI: 10.1016/j.actbio.2026.08.049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-10. Verfasst von George Ronan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bioengineering Graduate Program, University of Notre Dame, Notre Dame, IN, 46556, USA; Department of Aerospace and Mechanical Engineering, University…. Hauptthemen laut MEDLINE: Doxorubicin, Extracellular Vesicles, Paracrine Communication, Cardiotoxicity. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Cardiovascular disease (CVD) is the leading cause of death worldwide. Chemotherapy-induced CVD is increasingly recognized as a contributor to long-term morbidity in cancer survivors. Doxorubicin (DOX) is a widely used chemotherapeutic to treat breast cancer, one of the most common cancers in the United States. However, over 10% of treated women experience acute cardiotoxicity immediately following treatment, and approximately 2% develop severe cardiotoxicity up to 10 years after treatment, yet the mechanisms driving this delayed onset remain unclear. Here, we show that DOX treatment of cardiac cells changes their function and paracrine signaling profile. Subsequent exposure of healthy cells to altered extracellular vesicles (EVs) recapitulates the effects of direct DOX exposure in 2D/3D in vitro models, suggesting a mechanism for propagating initial injury. Plasma-EV miRNA profiling of blinded patient samples revealed distinct clustering by DOX-cardiotoxicity risk, with high-risk patients exhibiting miRNA signatures similar to those from DOX-treated models. Pathway analysis of miRNAs linked them to cardiac homeostasis and cardiotoxicity-related mechanisms, supporting the potential of plasma-EV miRNAs as noninvasive biomarkers for early risk stratification and personalized cardioprotective interventions in oncological care, and targeting of key miRNA clusters to enhance understanding of and intervention strategies for preventing the onset of DOX cardiotoxicity. STATEMENT OF SIGNIFICANCE: Doxorubicin is an effective chemotherapy drug, but its use is limited by cardiotoxicity that can appear during treatment or years later. The mechanisms driving this delayed injury remain poorly understood. In this study, we show for the first time that small EVs released from doxorubicin-treated human cardiac cells can propagate doxorubicin-like dysfunction to healthy human cardiac cells even in the absence of the drug itself. We further identify broad miRNA cargo changes in these EVs and show that related EV-associated miRNA shifts are also detectable in patient plasma. These findings provide new mechanistic insight into anthracycline cardiotoxicity and highlight EV-associated miRNAs as promising candidates for minimally invasive diagnosis and future therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioengineering Graduate Program, University of Notre Dame, Notre Dame, IN, 46556, USA; Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
- Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
- Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
- Discipline of Surgery, Lambe Institute for Translational Research, University of Galway, Galway, H91 V4AY, Ireland.
- Bioengineering Graduate Program, University of Notre Dame, Notre Dame, IN, 46556, USA; Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA; Department of Chemical and…
Förderung
- National Institutes of Health
Zitieren
APA
Ronan, G., Celebi, L. E., Kowalczyk, N., Behnam, N., Hawthorne, L., Yang, J., Ketchum, F., Lowery, A. J., Kerin, M. J., & Zorlutuna, P. (2026). Doxorubicin-induced Cardiotoxicity is Propagated by Paracrine Signaling through Small Extracellular Vesicles. Acta Biomaterialia, 223, 503-519. https://doi.org/10.1016/j.actbio.2026.08.049
Vancouver
Ronan G, Celebi LE, Kowalczyk N, Behnam N, Hawthorne L, Yang J, et al. Doxorubicin-induced Cardiotoxicity is Propagated by Paracrine Signaling through Small Extracellular Vesicles. Acta Biomaterialia. 2026;223:503-519. doi:10.1016/j.actbio.2026.08.049
BibTeX
@article{Ronan2026,
author = {Ronan, George and Celebi, Lara Ece and Kowalczyk, Nicole and Behnam, Noor and Hawthorne, Lauren and Yang, Jun and Ketchum, Frank and Lowery, Aoife J and Kerin, Michael J and Zorlutuna, Pinar},
title = {Doxorubicin-induced Cardiotoxicity is Propagated by Paracrine Signaling through Small Extracellular Vesicles},
journal = {Acta Biomaterialia},
year = {2026},
volume = {223},
pages = {503--519},
doi = {10.1016/j.actbio.2026.08.049}
}
EUVIMED